MEDLANDER released its performance for the first three quarters, with a net profit attributable to the parent company of 95.9987 million yuan, a year-on-year decrease of 0.07%
MEDLANDER released its third-quarter report for 2025, with revenue of 344 million yuan in the first three quarters, a year-on-year increase of 4.01%; net profit attributable to shareholders of 95.9987 million yuan, a year-on-year decrease of 0.07%; net profit excluding non-recurring gains and losses of 79.8 million yuan, a year-on-year decrease of 9.74%; basic earnings per share of 0.9813 yuan. The company plans to distribute a cash dividend of 3.00 yuan (including tax) for every 10 shares to all shareholders
According to the Zhitong Finance APP, MEDLANDER (688273.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 344 million yuan in the first three quarters, a year-on-year increase of 4.01%; the net profit attributable to shareholders of the listed company was 95.9987 million yuan, a year-on-year decrease of 0.07%; the net profit excluding non-recurring gains and losses was 79.8 million yuan, a year-on-year decrease of 9.74%; the basic earnings per share were 0.9813 yuan.
The company plans to distribute a cash dividend of 3.00 yuan (tax included) for every 10 shares to all shareholders
